Recombinant EBOV soluble GP
Order now: dominika@ksiazkiwnauce.pl
Recombinant EBOV GP-RBD Protein (aa 1-320) [Fc] |
|||
VAng-Wyb6917-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP-RBD Protein (aa 1-320) [Fc] |
|||
VAng-Wyb6917-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Soluble CD14 Recombinant Protein |
|||
40-198-001mg | ProSci | 0.01 mg | 311.1 EUR |
Description: CD14 is a cell surface anchored glycoprotein that is expressed predominantly by monocytes and tissue macrophages. CD14 associates with MD-2 (LY-96) and TLR4 to form a receptor complex, which signals specifically in response to bacterial lipopolysaccharide (LPS) binding. The CD14/MD-2/TLR4 receptor complex signals via MyD88, TIRAP, and TRAF6, and ultimately activates NF-kappa-β. CD14 also exists in a soluble form, designated as sCD14, which is capable of specifically binding LPS in the extracellular space. Recombinant sCD14 is a 331 amino acid glycoprotein comprising the extracellular portion of the CD14 receptor. |
|||
Soluble CD14 Recombinant Protein |
|||
40-198-005mg | ProSci | 0.05 mg | 437.1 EUR |
Description: CD14 is a cell surface anchored glycoprotein that is expressed predominantly by monocytes and tissue macrophages. CD14 associates with MD-2 (LY-96) and TLR4 to form a receptor complex, which signals specifically in response to bacterial lipopolysaccharide (LPS) binding. The CD14/MD-2/TLR4 receptor complex signals via MyD88, TIRAP, and TRAF6, and ultimately activates NF-kappa-β. CD14 also exists in a soluble form, designated as sCD14, which is capable of specifically binding LPS in the extracellular space. Recombinant sCD14 is a 331 amino acid glycoprotein comprising the extracellular portion of the CD14 receptor. |
|||
Soluble CD23 Recombinant Protein |
|||
40-315-0005mg | ProSci | 0.005 mg | 311.1 EUR |
Description: CD23, the low affinity receptor for IgE, belongs to the C-type lectin structural family and plays a role in the regulation of IgE synthesis and IgE mediated activities. It is found both as a transmembrane receptor protein and in a soluble form, which is generated by proteolytic cleavage of membrane bound CD23. The predominant soluble form of CD23 (sCD23) consists of 172 amino acids corresponding to the extracellular domain of the full length precursor. sCD23, in addition to binding IgE, also exerts a number of IgE independent activities, such as promoting the activation and differentiation of B-cells and stimulating the release of pro-inflammatory cytokines from monocytes. Recombinant human sCD23 is a 19.2 kDa non-glycosylated protein containing 172 amino-acid residues. |
|||
Soluble CD23 Recombinant Protein |
|||
40-315-002mg | ProSci | 0.02 mg | 437.1 EUR |
Description: CD23, the low affinity receptor for IgE, belongs to the C-type lectin structural family and plays a role in the regulation of IgE synthesis and IgE mediated activities. It is found both as a transmembrane receptor protein and in a soluble form, which is generated by proteolytic cleavage of membrane bound CD23. The predominant soluble form of CD23 (sCD23) consists of 172 amino acids corresponding to the extracellular domain of the full length precursor. sCD23, in addition to binding IgE, also exerts a number of IgE independent activities, such as promoting the activation and differentiation of B-cells and stimulating the release of pro-inflammatory cytokines from monocytes. Recombinant human sCD23 is a 19.2 kDa non-glycosylated protein containing 172 amino-acid residues. |
|||
FasL, Soluble Recombinant Protein |
|||
90-215 | ProSci | 10 ug | 468.6 EUR |
Description: FasL is a cytokine that binds to TNFRSF6/Fas, a receptor that transduces the apoptotic signal into cells. Is involved in cytotoxic T cell mediated apoptosis and in T cell development. |
|||
BAFF, Soluble Recombinant Protein |
|||
90-233 | ProSci | 10 ug | 437.1 EUR |
Description: BAFF is mainly produced by innate immune cells such as neutrophils, monocytes, macrophages, dendritic cells, follicular dendritic cells. T cells, activated B cells, some malignant B cells and also non-lymphoid cells like astrocytes, synoviocytes and epithelial cells can also produce BAFF. BAFF binds three distinct receptors (BAFF-R, TACI and BCMA) expressed predominantly on B cells, although activated T cells also express BAFF-R. BAFF is a master regulator of peripheral B cell survival, and together with IL-6, promotes Ig class-switching and plasma cell differentiation. Besides its major role in B cell biology, BAFF co-stimulates activated T cells. Deregulated expression of BAFF leads to autoimmune disorders in mice. In humans, elevated levels of soluble BAFF have been detected in the serum of patients with various autoimmune diseases such as Sjoegren syndrome, Rheumatoid arthritis (RA), Multiple sclerosis (MS) and Systemic Lupus Erythematosus (SLE). BAFF has also increased levels in some lymphoid cancers. |
|||
FasL Soluble Recombinant Protein |
|||
90-312 | ProSci | 10 ug | 600.9 EUR |
Description: Fc (human):FasL, Soluble (human) is a high activity construct in which two trimeric FasL are artificially linked via the Fc binding domain of human IgG1. This construct very effectively simulates the natural membrane-assisted aggregation of FasL in vivo. FasL is a cytokine that binds to TNFRSF6/Fas, a receptor that transduces the apoptotic signal into cells. It is involved in cytotoxic T cell mediated apoptosis and in T cell development. |
|||
GITRL, Soluble Recombinant Protein |
|||
90-004 | ProSci | 50 ug | 682.8 EUR |
Description: GITRL (Glucocorticoid-induced TNF receptor ligand) is expressed on dendritic cells (DC), monocytes, macrophages, B cells, activated T cells, endothelial cells, osteoclasts and various healthy non-lymphoid tissues (e. g. testis). GITRL is constitutively expressed and released as soluble form by solid tumors and various hematopoietic malignancies. GITRL causes differentiation of osteoclasts, activation of macrophages, but also alteration of carcinoma and leukemia cells and influences apoptosis. Binding to GITR is important in regulating T cell proliferation and TCR-mediated apoptosis. GITRL is implicated in development of autoimmune diseases and in the immune response against infectious pathogens and tumors. |
|||
TRAIL, Soluble Recombinant Protein |
|||
90-217 | ProSci | 10 ug | 468.6 EUR |
Description: TNF-related apoptosis-inducing ligand (TRAIL; Apo2L;CD253; TNFSF10) is a type II transmembrane protein of about 34kDa. Like most members of the tumor necrosis factor (TNF) superfamily of cytokines TRAIL can be cleaved at the cell surface by metalloproteases to form a soluble molecule. Active TRAIL forms trimers and specifically binds to fi ve distinct receptors: TRAIL-R1 (DR4; Apo2;CD261; TNFRSF10A), TRAIL-R2 (DR5; KILLER; TRICK2A;TRICK2B; CD262; TNFRSF10B), TRAIL-R3 (DcR1;LIT; TRID; CD263; TNFRSF10C), TRAIL-R4 (DcR2;TRUNDD; CD264; TNFRSF10D), and osteoprotegerin (OPG; OCIF; TNFRSF11B). Trimerized TRAIL triggers apoptosis upon ligation of cell surface TRAIL-R1 and/or TRAIL-R2 by inducingthe formation of the so-called multiprotein death-inducing signaling complex (DISC). |
|||
RANKL, Soluble Recombinant Protein |
|||
90-223 | ProSci | 10 ug | 600.9 EUR |
Description: RANKL is an osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T cell proliferation. Important regulator of interactions between T cells and dendritic cells and may play a role in the regulation of the T cell-dependent immune response. RANKL plays an important role in the progression of breast cancer. |
|||
LIGHT, Soluble Recombinant Protein |
|||
90-224 | ProSci | 10 ug | 437.1 EUR |
Description: LIGHT (HVEML; CD258) is a cytokine that binds to TNFRSF3/LTBR. It activates NF-kappaB, stimulates the proliferation of T cells, and inhibits growth of the adenocarcinoma HT-29. Acts as a receptor for Herpes simplex virus. |
|||
Rabbit anti-EBOV Soluble GP (sGP) pAb |
|||
0365-001 | IBT Bioservices | 100ug | 577.2 EUR |
Description:
|
|||
izTRAIL, Soluble Recombinant Protein |
|||
90-257 | ProSci | 10 ug | 500.1 EUR |
Description: izTRAIL is a newly available, highly active recombinant form of soluble human TRAIL. Due to a trimerizing N-terminal isoleucine zipper (iz) motif the intrinsic trimerization of TRAIL, required for apoptosis-inducing activity of TRAIL, is enhanced when compared to non-tagged soluble human TRAIL (shTRAIL). Therefore, izTRAIL is a potent inducer of apoptosis in many human cancer cells, but not normal human hepatocytes. In addition, the half-life of izTRAIL is about eight-fold higher than the half-life of shTRAIL. These properties render izTRAIL highly suitable for both, in vitro and in vivo use, particularly for studies in which investigators plan to transfer their in vitro results into an in vivo system with human cancer cells in xenotransplant settings examining susceptibility to TRAIL-induced apoptosis. |
|||
Recombinant EBOV VP24 |
|||
0501-030 | IBT Bioservices | 100ug | 589.2 EUR |
Description:
|
|||
Recombinant EBOV VP40 |
|||
0564-001 | IBT Bioservices | 100ug | 589.2 EUR |
Description:
|
|||
Recombinant EBOV VLPs |
|||
VAng-Lsx0139-inquire | Creative Biolabs | inquire | Ask for price |
Description: EBOV Virus-Like Particles, recombinant protein from Sf9 cells. |
|||
EDA-A1, Soluble Recombinant Protein |
|||
90-288 | ProSci | 10 ug | 437.1 EUR |
Description: The TNF family ligand ectodysplasin A (EDA) and its receptor EDAR are required for proper development of skin appendages such as hair, teeth, and eccrine sweat glands. Loss of function mutations in the Eda gene cause X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition that can be ameliorated in mice and dogs by timely administration of recombinant EDA. The Eda gene on the X chromosome is transcribed as multiple splice variants, only two of which code for the receptor-binding C-terminal TNF homology domain. These two variants code for 391- and 389-amino acid-long proteins called EDA1 and EDA2. EDA1 binds EDAR, whereas EDA2 binds to another receptor, XEDAR. The biology of EDA2 and XEDAR is distinct from that of EDA1. Indeed, XEDAR-deficient mice have no obvious ectodermal dysplasia phenotype, whereas mice deficient in EDA, EDAR, or the signaling adaptor protein EDARADD all display virtually indistinguishable ectodermal dysplasia phenotypes, indicating the predominance of the EDA1-EDAR axis in the development of skin-derived appendages. |
|||
KillerTRAIL, Soluble Recombinant Protein |
|||
90-335 | ProSci | 50 ug | 682.8 EUR |
Description: TNF-related apoptosis-inducing ligand (TRAIL; Apo2L;CD253; TNFSF10) is a type II transmembrane protein of about 34kDa. Like most members of the tumor necrosis factor (TNF) superfamily of cytokines TRAIL can be cleaved at the cell surface by metalloproteases to form a soluble molecule. Active TRAIL forms trimers and specifically binds to five distinct receptors: TRAIL-R1 (DR4; Apo2;CD261; TNFRSF10A), TRAIL-R2 (DR5; KILLER; TRICK2A;TRICK2B; CD262; TNFRSF10B), TRAIL-R3 (DcR1;LIT; TRID; CD263; TNFRSF10C), TRAIL-R4 (DcR2;TRUNDD; CD264; TNFRSF10D), and osteoprotegerin (OPG; OCIF; TNFRSF11B). Trimerized TRAIL triggers apoptosis upon ligation of cell surface TRAIL-R1 and/or TRAIL-R2 by inducing the formation of the so-called multiprotein death-inducing signaling complex (DISC). |
|||
Recombinant Human Soluble RANK Ligand |
|||
CG146-002 | GenDepot | 2ug | 351.6 EUR |
Recombinant Human Soluble RANK Ligand |
|||
CG146-010 | GenDepot | 10ug | 489.6 EUR |
Recombinant Human Soluble RANK Ligand |
|||
CG146-101 | GenDepot | 1mg | 12372 EUR |
Recombinant Human Soluble RANK Ligand |
|||
7-01492 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Soluble RANK Ligand |
|||
7-01493 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Soluble RANK Ligand |
|||
7-01494 | CHI Scientific | 1mg | Ask for price |
Recombinant Mouse Soluble RANK Ligand |
|||
7-01501 | CHI Scientific | 2µg | Ask for price |
Recombinant Mouse Soluble RANK Ligand |
|||
7-01502 | CHI Scientific | 10µg | Ask for price |
Recombinant Mouse Soluble RANK Ligand |
|||
7-01503 | CHI Scientific | 1mg | Ask for price |
Human Soluble RANK Ligand (Recombinant) |
|||
22060486-1 | Glycomatrix | 2 µg | 146.42 EUR |
Recombinant EBOV Protein |
|||
VAng-Lsx0136-1mg | Creative Biolabs | 1 mg | 1365.6 EUR |
Description: EBOV, recombinant protein from E. coli. |
|||
Recombinant EBOV GP Protein (aa 1-501) [His] (HEK293 Cells) |
|||
VAng-Wyb6904-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-501) [His] (HEK293 Cells) |
|||
VAng-Wyb6904-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-637) [His] (HEK293 Cells) |
|||
VAng-Wyb6906-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-637) [His] (HEK293 Cells) |
|||
VAng-Wyb6906-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-650) [His] (HEK293 Cells) |
|||
VAng-Wyb6909-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-650) [His] (HEK293 Cells) |
|||
VAng-Wyb6909-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein, recombinant protein. |
|||
Soluble RANK Ligand Recombinant Protein |
|||
40-296-0002mg | ProSci | 0.002 mg | 311.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Recombinant human sRANKL is a 20.0 kDa polypeptide comprising the TNF homologous region of RANKL (176 amino acid residues). |
|||
Soluble RANK Ligand Recombinant Protein |
|||
40-296-001mg | ProSci | 0.01 mg | 437.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Recombinant human sRANKL is a 20.0 kDa polypeptide comprising the TNF homologous region of RANKL (176 amino acid residues). |
|||
Soluble RANK Ligand Recombinant Protein |
|||
40-451-0002mg | ProSci | 0.002 mg | 311.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Recombinant murine sRANKL is a 19.4 kDa polypeptide comprising the TNF homologous region of RANKL (174 amino acid residues). |
|||
Soluble RANK Ligand Recombinant Protein |
|||
40-451-001mg | ProSci | 0.01 mg | 437.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Recombinant murine sRANKL is a 19.4 kDa polypeptide comprising the TNF homologous region of RANKL (174 amino acid residues). |
|||
Soluble CD40 Ligand Recombinant Protein |
|||
40-455-0005mg | ProSci | 0.005 mg | 311.1 EUR |
Description: CD40, a member of the TNF receptor family, is a cell surface protein expressed on B cells, dendritic cells, monocytes, thymic epithelial cells and, at low levels, on T cells. Signaling though CD40 plays an important role in the proliferation and differentiation of B cells, and is critical for immunoglobulin (Ig) class switching. The membrane-anchored CD40-Ligand is expressed almost exclusively on activated CD4+ T lymphocytes. Failure to express CD40L leads to "immunodeficiency with hyper-IgM", a disease characterized by failure to produce IgG, IgA and IgE. The soluble form of CD40L is an 18kDa protein comprising the entire TNF homologous region of CD40L and is generated in vivo by an intracellular proteolytic processing of the full length CD40L. Recombinant murine CD40L is a soluble 16.4 kDa protein containing 149 amino acid residues comprising the receptor binding TNF-like domain of CD40L. |
|||
Soluble CD40 Ligand Recombinant Protein |
|||
40-455-0025mg | ProSci | 0.025 mg | 437.1 EUR |
Description: CD40, a member of the TNF receptor family, is a cell surface protein expressed on B cells, dendritic cells, monocytes, thymic epithelial cells and, at low levels, on T cells. Signaling though CD40 plays an important role in the proliferation and differentiation of B cells, and is critical for immunoglobulin (Ig) class switching. The membrane-anchored CD40-Ligand is expressed almost exclusively on activated CD4+ T lymphocytes. Failure to express CD40L leads to "immunodeficiency with hyper-IgM", a disease characterized by failure to produce IgG, IgA and IgE. The soluble form of CD40L is an 18kDa protein comprising the entire TNF homologous region of CD40L and is generated in vivo by an intracellular proteolytic processing of the full length CD40L. Recombinant murine CD40L is a soluble 16.4 kDa protein containing 149 amino acid residues comprising the receptor binding TNF-like domain of CD40L. |
|||
Soluble RANK Ligand Recombinant Protein |
|||
40-481-0002mg | ProSci | 0.002 mg | 311.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Recombinant rat sRANKL is a 19.4 kDa polypeptide comprising the TNF homologous region of RANKL (174 amino acid residues). |
|||
Soluble RANK Ligand Recombinant Protein |
|||
40-481-001mg | ProSci | 0.01 mg | 437.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T-cell proliferation in a mixed lymphocyte reaction, to promote the survival of RANK + T cells, and to regulate T-cell-dependent immune response. RANKL, which is expressed in a variety of cells including osteoblasts, fibroblasts, activated T-cells and bone marrow stromal cells, is also capable of interacting with a decoy receptor called OPG. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. Recombinant rat sRANKL is a 19.4 kDa polypeptide comprising the TNF homologous region of RANKL (174 amino acid residues). |
|||
TNF-alpha, Soluble Recombinant Protein |
|||
90-221 | ProSci | 10 ug | 342.6 EUR |
Description: Tumor necrosis factor (TNF, cachexin or cachectin and formerly known as tumor necrosis factor-alpha) is a cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction. The receptor TNF-R1 is activated by both the membrane-bound and soluble trimeric forms of TNF-alpha, whereas the receptor TNF-R2 only responds to the membrane-bound form of TNF-alpha (MultimericTNF-alpha (Prod. No. AG-40B-0019). Since the MultimericTNF-alpha mimics the membrane-bound form (forms oligomers higher than trimer), it is the only TNF-alpha protein that can activate the TNF-R2. For TNF-R1 activation, either "normal" TNF-alpha or MultimericTNF-alpha can be used. |
|||
TNF-alpha, Soluble Recombinant Protein |
|||
90-222 | ProSci | 50 ug | 468.6 EUR |
Description: Tumor necrosis factor (TNF, cachexin or cachectin and formerly known as tumor necrosis factor-alpha) is a cytokine involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction. The receptor TNF-R1 is activated by both the membrane-bound and soluble trimeric forms of TNF-alpha, whereas the receptor TNF-R2 only responds to the membrane-bound form of TNF-alpha (MultimericTNF-alpha (Prod. No. AG-40B-0019). Since the MultimericTNF-alpha mimics the membrane-bound form (forms oligomers higher than trimer), it is the only TNF-alpha protein that can activate the TNF-R2. For TNF-R1 activation, either "normal" TNF-alpha or MultimericTNF-alpha can be used. |
|||
Soluble Fas Receptor Recombinant Protein |
|||
40-311-0005mg | ProSci | 0.005 mg | 311.1 EUR |
Description: Fas and Fas Ligand (FasL) belong to the TNF superfamily and are type I and type II transmembrane proteins, respectively. Binding of FasL to Fas triggers apoptosis in Fas-bearing cells. The mechanism of apoptosis involves recruitment of pro-caspase 8 through an adaptor molecule called FADD followed by processing of the pro-enzyme to active forms. These active caspases then cleave various cellular substrates leading to the eventual cell death. sFasR is capable of inhibiting FasL-induced apoptosis by acting as a decoy receptor that serves as a sink for FasL. The full length Fas (receptor) is a 319 amino acid type I transmembrane protein, which contains a 157 amino acid extracellular domain, a 17 amino acid transmembrane domain, and 145 amino acid cytoplasmic domain. Recombinant human soluble Fas (sFas Receptor) is a 157 amino acid polypeptide (17.6 kDa) corresponding to the TNFR homologous cysteine rich extracellular domain Fas. |
|||
Soluble Fas Receptor Recombinant Protein |
|||
40-311-002mg | ProSci | 0.02 mg | 437.1 EUR |
Description: Fas and Fas Ligand (FasL) belong to the TNF superfamily and are type I and type II transmembrane proteins, respectively. Binding of FasL to Fas triggers apoptosis in Fas-bearing cells. The mechanism of apoptosis involves recruitment of pro-caspase 8 through an adaptor molecule called FADD followed by processing of the pro-enzyme to active forms. These active caspases then cleave various cellular substrates leading to the eventual cell death. sFasR is capable of inhibiting FasL-induced apoptosis by acting as a decoy receptor that serves as a sink for FasL. The full length Fas (receptor) is a 319 amino acid type I transmembrane protein, which contains a 157 amino acid extracellular domain, a 17 amino acid transmembrane domain, and 145 amino acid cytoplasmic domain. Recombinant human soluble Fas (sFas Receptor) is a 157 amino acid polypeptide (17.6 kDa) corresponding to the TNFR homologous cysteine rich extracellular domain Fas. |
|||
Recombinant EBOV gp Protein (Minus The Transmembrane Region) [HA] |
|||
VAng-Lsx0142-inquire | Creative Biolabs | inquire | Ask for price |
Description: EBOV GPDTM, recombinant protein from mammalian cells. |
|||
Recombinant EBOV (subtype Zaire,strain Kikwit-95) Envelope GP |
|||
E40VAG340 | EnoGene | 20ug | 495 EUR |
Soluble RANK Receptor Recombinant Protein |
|||
40-300-002mg | ProSci | 0.02 mg | 311.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T cell proliferation and to promote the survival of RANK + T cells. RANK is also expressed in a variety of tissues including skeletal muscle, thymus, liver, colon, small intestine and adrenal gland. The RANK/RANKL interaction is important in the regulation of osteoclastogenesis and in dendritic-cell-mediated T cell immune responses. Impairments in RANK signaling have been implicated in the induction of expansile osteolysis and Paget disease of bone (PDB2). Recombinant human sRANK receptor is a 19.3 kDa polypeptide containing the TNFR homologous cysteine rich portion of the extracellular domain of RANK receptor (175 amino acid residues). |
|||
Soluble RANK Receptor Recombinant Protein |
|||
40-300-01mg | ProSci | 0.1 mg | 437.1 EUR |
Description: RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naïve T cell proliferation and to promote the survival of RANK + T cells. RANK is also expressed in a variety of tissues including skeletal muscle, thymus, liver, colon, small intestine and adrenal gland. The RANK/RANKL interaction is important in the regulation of osteoclastogenesis and in dendritic-cell-mediated T cell immune responses. Impairments in RANK signaling have been implicated in the induction of expansile osteolysis and Paget disease of bone (PDB2). Recombinant human sRANK receptor is a 19.3 kDa polypeptide containing the TNFR homologous cysteine rich portion of the extracellular domain of RANK receptor (175 amino acid residues). |
|||
B3GNT6, soluble fragment, Human Recombinant |
|||
P1221-5 | Biovision | each | 288 EUR |
Recombinant EBOV gp Protein (Minus The Transmembrane Region) [His] |
|||
VAng-Lsx0141-inquire | Creative Biolabs | inquire | Ask for price |
Description: EBOV GPDTM, recombinant protein from Sf9 cells. |
|||
SuperKillerTRAIL, Soluble Recombinant Protein |
|||
90-336 | ProSci | 20 ug | 682.8 EUR |
Description: TNF-related apoptosis-inducing ligand (TRAIL; Apo2L;CD253; TNFSF10) is a type II transmembrane protein of about 34kDa. Like most members of the tumor necrosis factor (TNF) superfamily of cytokines TRAIL can be cleaved at the cell surface by metalloproteases to form a soluble molecule. Active TRAIL forms trimers and specifically binds to five distinct receptors: TRAIL-R1 (DR4; Apo2;CD261; TNFRSF10A), TRAIL-R2 (DR5; KILLER; TRICK2A;TRICK2B; CD262; TNFRSF10B), TRAIL-R3 (DcR1;LIT; TRID; CD263; TNFRSF10C), TRAIL-R4 (DcR2; TRUNDD; CD264; TNFRSF10D), and osteoprotegerin (OPG; OCIF; TNFRSF11B). Trimerized TRAIL triggers apoptosis upon ligation of cell surface TRAIL-R1 and/or TRAIL-R2 by inducing the formation of the so-called multiprotein death-inducing signaling complex (DISC). |
|||
SuperKillerTRAIL, Soluble Recombinant Protein |
|||
90-338 | ProSci | 20 ug | 682.8 EUR |
Description: TNF-related apoptosis-inducing ligand (TRAIL; Apo2L;CD253; TNFSF10) is a type II transmembrane protein of about 34kDa. Like most members of the tumor necrosis factor (TNF) superfamily of cytokines TRAIL can be cleaved at the cell surface by metalloproteases to form a soluble molecule. Active TRAIL forms trimers and specifically binds to five distinct receptors: TRAIL-R1 (DR4; Apo2;CD261; TNFRSF10A), TRAIL-R2 (DR5; KILLER; TRICK2A;TRICK2B; CD262; TNFRSF10B), TRAIL-R3 (DcR1;LIT; TRID; CD263; TNFRSF10C), TRAIL-R4 (DcR2; TRUNDD; CD264; TNFRSF10D), and osteoprotegerin (OPG; OCIF; TNFRSF11B). Trimerized TRAIL triggers apoptosis upon ligation of cell surface TRAIL-R1 and/or TRAIL-R2 by inducing the formation of the so-called multiprotein death-inducing signaling complex (DISC). |
|||
Recombinant Rat Prolactin Soluble Receptor |
|||
CG108-010 | GenDepot | 10ug | 351.6 EUR |
Recombinant Rat Prolactin Soluble Receptor |
|||
CG108-050 | GenDepot | 50ug | 489.6 EUR |
Recombinant Rat Prolactin Soluble Receptor |
|||
CG108-101 | GenDepot | 1mg | 4110 EUR |
Recombinant Rat Prolactin Soluble Receptor |
|||
7-01447 | CHI Scientific | 5µg | Ask for price |
Recombinant Rat Prolactin Soluble Receptor |
|||
7-01448 | CHI Scientific | 20µg | Ask for price |
Recombinant Rat Prolactin Soluble Receptor |
|||
7-01449 | CHI Scientific | 1mg | Ask for price |
B4GalT1, soluble fragment, Human Recombinant |
|||
P1222-5 | Biovision | each | 288 EUR |
ST3Gal1, soluble fragment, Human Recombinant |
|||
P1224-5 | Biovision | each | 288 EUR |
Recombinant EBOV GP Protein (aa 1-650, 309-484 deleted) [His] |
|||
VAng-Wyb6910-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein (Virion spike glycoprotein), recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-650, 309-484 deleted) [His] |
|||
VAng-Wyb6910-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein (Virion spike glycoprotein), recombinant protein. |
|||
Recombinant Ovine Prolactin Soluble Receptor |
|||
CG111-010 | GenDepot | 10ug | 351.6 EUR |
Recombinant Ovine Prolactin Soluble Receptor |
|||
CG111-050 | GenDepot | 50ug | 489.6 EUR |
Recombinant Ovine Prolactin Soluble Receptor |
|||
CG111-101 | GenDepot | 1mg | 4110 EUR |
Recombinant Ovine Prolactin Soluble Receptor |
|||
7-01438 | CHI Scientific | 5µg | Ask for price |
Recombinant Ovine Prolactin Soluble Receptor |
|||
7-01439 | CHI Scientific | 20µg | Ask for price |
Recombinant Ovine Prolactin Soluble Receptor |
|||
7-01440 | CHI Scientific | 1mg | Ask for price |
Ovine Prolactin Soluble Receptor (Recombinant) |
|||
22060686-1 | Glycomatrix | 10 µg | 146.42 EUR |
Recombinant Human soluble CD40 Ligand/TRAP |
|||
7-01468 | CHI Scientific | 10µg | Ask for price |
Recombinant Human soluble CD40 Ligand/TRAP |
|||
7-01469 | CHI Scientific | 50µg | Ask for price |
Recombinant Human soluble CD40 Ligand/TRAP |
|||
7-01470 | CHI Scientific | 1mg | Ask for price |
Recombinant Mouse soluble CD40 Ligand/TRAP |
|||
7-01474 | CHI Scientific | 5µg | Ask for price |
Recombinant Mouse soluble CD40 Ligand/TRAP |
|||
7-01475 | CHI Scientific | 25µg | Ask for price |
Recombinant Mouse soluble CD40 Ligand/TRAP |
|||
7-01476 | CHI Scientific | 1mg | Ask for price |
sCD4 Soluble CD4 Human Recombinant Protein |
|||
PROTP01730 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: sCD4 Human Recombinant produced in Baculovirus is a single, glycosylated polypeptide chain containing 365 amino acids and having a non glycosilated molecular mass of 45 kDa. As a result of glycosilation the sCD4 migrates as a 46 kDa protein on standard SDS-PAGE. Detected By Western Imunno Blots anti CD4 monoclonal antibody.;The sCD4 is purified by proprietary chromatographic techniques. |
|||
Human soluble CD40 Ligand/TRAP (Recombinant) |
|||
22060485-1 | Glycomatrix | 10 µg | 146.42 EUR |
Recombinant EBOV GPDTM (S2) |
|||
0501-025 | IBT Bioservices | 100ug | 662.4 EUR |
Description:
|
|||
Recombinant EBOV GPDTM (S2) |
|||
0501-026 | IBT Bioservices | 500ug | 2470.8 EUR |
Description:
|
|||
Recombinant EBOV Zaire NP |
|||
VAng-Lsx0137-inquire | Creative Biolabs | inquire | Ask for price |
Description: Recombinant Ebola Zaire Nucleoprotein (NP), contains the C-terminal portion of the Ebola Zaire nucleoprotein. Molecular weight is 15 kDa. |
|||
Recombinant Rabbit Prolactin Soluble Receptor |
|||
7-01435 | CHI Scientific | 5µg | Ask for price |
Recombinant Rabbit Prolactin Soluble Receptor |
|||
7-01436 | CHI Scientific | 20µg | Ask for price |
Recombinant Rabbit Prolactin Soluble Receptor |
|||
7-01437 | CHI Scientific | 1mg | Ask for price |
Recombinant Bovine Prolactin Soluble Receptor |
|||
7-01441 | CHI Scientific | 5µg | Ask for price |
Recombinant Bovine Prolactin Soluble Receptor |
|||
7-01442 | CHI Scientific | 20µg | Ask for price |
Recombinant Bovine Prolactin Soluble Receptor |
|||
7-01443 | CHI Scientific | 1mg | Ask for price |
Rabbit Prolactin Soluble Receptor (Recombinant) |
|||
22060652-1 | Glycomatrix | 10 µg | 146.42 EUR |
Recombinant Thymidine Kinase 1, Soluble (TK1) |
|||
4-RPC823Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Thymidine Kinase 1, Soluble expressed in: E.coli |
|||
ST6GalNAc1, soluble fragment, Human Recombinant |
|||
P1223-5 | Biovision | each | 288 EUR |
Recombinant EBOV GPDTM (Sf9) |
|||
0501-015 | IBT Bioservices | 100ug | 589.2 EUR |
Description:
|
|||
Recombinant EBOV GPDTM (Sf9) |
|||
0501-016 | IBT Bioservices | 500ug | 2179.2 EUR |
Description:
|
|||
sCD23 Soluble CD23 Human Recombinant Protein |
|||
PROTP06734-1 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: sCD23 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 172 amino acids and having a molecular mass of 19.2kDa. |
|||
Recombinant EBOV GPΔmuc (Sf9) |
|||
0511-015 | IBT Bioservices | 100ug | 589.2 EUR |
Description:
|
|||
Recombinant (E. coli) HIV gp36 protein (soluble) |
|||
HGP362-R | Alpha Diagnostics | 100 ug | 343.2 EUR |
Soluble TRAIL Receptor-1 Recombinant Protein |
|||
40-309-001mg | ProSci | 0.01 mg | 311.1 EUR |
Description: TRAIL Receptor-1/DR4 and TRAIL Receptor-2/DR5 belong to the TNFR superfamily of transmembrane proteins and contain a cytoplasmic "death domain, " which can activate the cell's apoptotic machinery. These receptors are activated by binding to either membrane anchored or soluble TRAIL/Apo2L. Recombinant human soluble TRAIL Receptor-1/DR4 is a 22.7 kDa protein (215 amino acid residues) consisting of the TNFR homologous, cysteine rich portion of the extracellular domain. |
|||
Soluble TRAIL Receptor-1 Recombinant Protein |
|||
40-309-005mg | ProSci | 0.05 mg | 437.1 EUR |
Description: TRAIL Receptor-1/DR4 and TRAIL Receptor-2/DR5 belong to the TNFR superfamily of transmembrane proteins and contain a cytoplasmic "death domain, " which can activate the cell's apoptotic machinery. These receptors are activated by binding to either membrane anchored or soluble TRAIL/Apo2L. Recombinant human soluble TRAIL Receptor-1/DR4 is a 22.7 kDa protein (215 amino acid residues) consisting of the TNFR homologous, cysteine rich portion of the extracellular domain. |
|||
Soluble TRAIL Receptor-2 Recombinant Protein |
|||
40-310-001mg | ProSci | 0.01 mg | 311.1 EUR |
Description: TRAIL Receptor-1/DR4 and TRAIL Receptor-2/DR5 belong to the TNFR superfamily of transmembrane proteins and contain a cytoplasmic "death domain", which can activate the cell's apoptotic machinery. These receptors are activated by binding to either membrane anchored or soluble TRAIL/Apo2L. Recombinant human soluble TRAIL Receptor-2/DR5 is a 14.9 kDa protein (133 amino acid residues) consisting of the TNFR homologous, cysteine rich portion of the extracellular domain. |
|||
Soluble TRAIL Receptor-2 Recombinant Protein |
|||
40-310-005mg | ProSci | 0.05 mg | 437.1 EUR |
Description: TRAIL Receptor-1/DR4 and TRAIL Receptor-2/DR5 belong to the TNFR superfamily of transmembrane proteins and contain a cytoplasmic "death domain", which can activate the cell's apoptotic machinery. These receptors are activated by binding to either membrane anchored or soluble TRAIL/Apo2L. Recombinant human soluble TRAIL Receptor-2/DR5 is a 14.9 kDa protein (133 amino acid residues) consisting of the TNFR homologous, cysteine rich portion of the extracellular domain. |
|||
GalNAc-T2, soluble fragment, Human Recombinant |
|||
P1215-5 | Biovision | each | 288 EUR |
GalNAc-T3, soluble fragment, Human Recombinant |
|||
P1216-5 | Biovision | each | 288 EUR |
GalNAc-T5, soluble fragment, Human Recombinant |
|||
P1217-5 | Biovision | each | 288 EUR |
Recombinant Human Soluble RANK Ligand, His Tag |
|||
7-01495 | CHI Scientific | 5µg | Ask for price |
Recombinant Human Soluble RANK Ligand, His Tag |
|||
7-01496 | CHI Scientific | 20µg | Ask for price |
Recombinant Human Soluble RANK Ligand, His Tag |
|||
7-01497 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Soluble RANK Ligand, GST Tag |
|||
7-01498 | CHI Scientific | 2µg | Ask for price |
Recombinant Human Soluble RANK Ligand, GST Tag |
|||
7-01499 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Soluble RANK Ligand, GST Tag |
|||
7-01500 | CHI Scientific | 0.1mg | Ask for price |
GalNAc-T16, soluble fragment, Human Recombinant |
|||
P1218-5 | Biovision | each | 288 EUR |
Recombinant Human Soluble IL-6 Receptor alpha |
|||
7-00892 | CHI Scientific | 5µg | Ask for price |
Recombinant Human Soluble IL-6 Receptor alpha |
|||
7-00893 | CHI Scientific | 20µg | Ask for price |
Recombinant Human Soluble IL-6 Receptor alpha |
|||
7-00894 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Soluble IL-6 Receptor alpha |
|||
CC049-005 | GenDepot | 5ug | 351.6 EUR |
Recombinant Human Soluble IL-6 Receptor alpha |
|||
CC049-020 | GenDepot | 20ug | 489.6 EUR |
Recombinant Human Soluble IL-6 Receptor alpha |
|||
CC049-101 | GenDepot | 1mg | 9618 EUR |
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Bo01 | Cloud-Clone |
|
|
Description: Recombinant Bovine Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Eq01 | Cloud-Clone |
|
|
Description: Recombinant Horse Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Ga01 | Cloud-Clone |
|
|
Description: Recombinant Chicken Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Ov01 | Cloud-Clone |
|
|
Description: Recombinant Sheep Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Po01 | Cloud-Clone |
|
|
Description: Recombinant Pig Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant Superoxide Dismutase 1, Soluble (SOD1) |
|||
4-RPB960Rb01 | Cloud-Clone |
|
|
Description: Recombinant Rabbit Superoxide Dismutase 1, Soluble expressed in: E.coli |
|||
Recombinant human Brain acid soluble protein 1 |
|||
P2930 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human Brain acid soluble protein 1 |
|||
Soluble TNF Receptor Type I Recombinant Protein |
|||
40-299-0005mg | ProSci | 0.005 mg | 311.1 EUR |
Description: TNFR1 belongs to the TNFR superfamily of transmembrane proteins, and is expressed in most cell types. Binding of either TNF-α or TNF-β to TNFR1 initiates a signal transduction pathway that results in the activation of the transduction factor NFκB, whose target genes are involved in the regulation of inflammatory responses, and, in certain cells induce apoptosis. Soluble TNF Receptor I (sTNFR1) is capable of inhibiting TNF-α and TNF-β activities by acting as a decoy receptor that serves as a sink for the TNF ligands. Recombinant human sTNFR1 is an 18.3 kDa protein (162 amino acid residues) comprising the cysteine rich ligand binding portion of the extracellular domain of the TNFR1 protein. |
|||
Soluble TNF Receptor Type I Recombinant Protein |
|||
40-299-002mg | ProSci | 0.02 mg | 437.1 EUR |
Description: TNFR1 belongs to the TNFR superfamily of transmembrane proteins, and is expressed in most cell types. Binding of either TNF-α or TNF-β to TNFR1 initiates a signal transduction pathway that results in the activation of the transduction factor NFκB, whose target genes are involved in the regulation of inflammatory responses, and, in certain cells induce apoptosis. Soluble TNF Receptor I (sTNFR1) is capable of inhibiting TNF-α and TNF-β activities by acting as a decoy receptor that serves as a sink for the TNF ligands. Recombinant human sTNFR1 is an 18.3 kDa protein (162 amino acid residues) comprising the cysteine rich ligand binding portion of the extracellular domain of the TNFR1 protein. |
|||
Soluble TNF Receptor Type II Recombinant Protein |
|||
40-304-0005mg | ProSci | 0.005 mg | 311.1 EUR |
Description: TNFRII is a member of the TNFR family of transmembrane proteins, and is expressed in immune cells and certain endothelial cells. It is a high affinity receptor for TNF-α but manifests a lower affinity to TNF-β. Signaling through this receptor regulates various biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, and neurotransmission. Soluble TNFRII is capable of inhibiting TNF-α induced activities by acting as a decoy receptor. Recombinant human sTNFRII is an 18.9 kDa protein (174 amino acid residues) comprising the cysteine rich ligand binding portion of the extracellular domain of the TNFRII protein. |
|||
Soluble TNF Receptor Type II Recombinant Protein |
|||
40-304-002mg | ProSci | 0.02 mg | 437.1 EUR |
Description: TNFRII is a member of the TNFR family of transmembrane proteins, and is expressed in immune cells and certain endothelial cells. It is a high affinity receptor for TNF-α but manifests a lower affinity to TNF-β. Signaling through this receptor regulates various biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, and neurotransmission. Soluble TNFRII is capable of inhibiting TNF-α induced activities by acting as a decoy receptor. Recombinant human sTNFRII is an 18.9 kDa protein (174 amino acid residues) comprising the cysteine rich ligand binding portion of the extracellular domain of the TNFRII protein. |
|||
Recombinant (E. coli) HIV-1 p24 protein (soluble) |
|||
HP241-R | Alpha Diagnostics | 100 ug | 270 EUR |
Recombinant EBOV GPDTM (mammalian) |
|||
0501-001 | IBT Bioservices | 100ug | 662.4 EUR |
Description:
|
|||
Recombinant (E. coli) HIV-1 gp41, protein (soluble) |
|||
HGP411-R | Alpha Diagnostics | 100 ug | 343.2 EUR |
Human Soluble CD14 Recombinant Protein Lyophilized |
|||
IHUSCD14RLY10UG | Innovative research | each | 341 EUR |
Description: Human Soluble CD14 Recombinant Protein Lyophilized |
|||
Human Soluble CD23 Recombinant Protein Lyophilized |
|||
IHUSCD23RLY5UG | Innovative research | each | 341 EUR |
Description: Human Soluble CD23 Recombinant Protein Lyophilized |
|||
Human GITRL, Soluble Recombinant Protein DDDDK Tag |
|||
IHUGITRLSRDDDDK50UG | Innovative research | each | 802 EUR |
Description: Human GITRL, Soluble Recombinant Protein DDDDK Tag |
|||
Recombinant Raibow Trout Prolactin Soluble Receptor |
|||
7-01444 | CHI Scientific | 5µg | Ask for price |
Recombinant Raibow Trout Prolactin Soluble Receptor |
|||
7-01445 | CHI Scientific | 20µg | Ask for price |
Recombinant Raibow Trout Prolactin Soluble Receptor |
|||
7-01446 | CHI Scientific | 1mg | Ask for price |
Recombinant EBOV Zaire NP [His] |
|||
VAng-Lsx0138-inquire | Creative Biolabs | inquire | Ask for price |
Description: Ebola Zaire nucleoprotein, recombinant protein from E. coli. |
|||
Recombinant EBOV GP Protein (aa 1-501) [His] (Baculovirus-Insect Cells) |
|||
VAng-Wyb6903-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-501) [His] (Baculovirus-Insect Cells) |
|||
VAng-Wyb6903-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Sudan, strain Gulu) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-637) [His] (Baculovirus-Insect Cells) |
|||
VAng-Wyb6905-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Sudan, strain Uganda-00) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-637) [His] (Baculovirus-Insect Cells) |
|||
VAng-Wyb6905-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Sudan, strain Uganda-00) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-650) [His] (Baculovirus-Insect Cells) |
|||
VAng-Wyb6908-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-650) [His] (Baculovirus-Insect Cells) |
|||
VAng-Wyb6908-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein, recombinant protein. |
|||
Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) |
|||
4-RPH839Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Isocitrate Dehydrogenase 1, Soluble expressed in: E.coli |
|||
Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) |
|||
4-RPH839Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Isocitrate Dehydrogenase 1, Soluble expressed in: E.coli |
|||
Recombinant Isocitrate Dehydrogenase 1, Soluble (IDH1) |
|||
4-RPH839Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Isocitrate Dehydrogenase 1, Soluble expressed in: E.coli |
|||
Recombinant Human soluble CD40 Ligand/TRAP His Tag |
|||
7-01471 | CHI Scientific | 5µg | Ask for price |
Recombinant Human soluble CD40 Ligand/TRAP His Tag |
|||
7-01472 | CHI Scientific | 20µg | Ask for price |
Recombinant Human soluble CD40 Ligand/TRAP His Tag |
|||
7-01473 | CHI Scientific | 1mg | Ask for price |
sRANKL RANK Ligand Soluble Human Recombinant Protein |
|||
PROTO14788 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: sRANKL Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 175 amino acids and having a molecular mass of 19.7kDa. |
|||
sRANKL RANK Ligand Soluble Mouse Recombinant Protein |
|||
PROTO35235 | BosterBio | Regular: 10ug | 380.4 EUR |
Description: sRANKL Mouse Recombinant produced in E.coli is single, non-glycosylated, polypeptide chain containing 160 amino acids and having a total molecular mass of 17.9kDa. CD254 is purified by proprietary chromatographic techniques. |
|||
sRANK Soluble RANK Receptor Human Recombinant Protein |
|||
PROTQ9Y6Q6 | BosterBio | Regular: 100ug | 380.4 EUR |
Description: sRANK Receptor Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 174 amino acids and having a molecular mass of 19.1kDa. ;The sRANK Receptor is purified by proprietary chromatographic techniques. |
|||
Recombinant Reston EBOV gp Protein (Minus The Transmembrane Region) [His] |
|||
VAng-Lsx0145-inquire | Creative Biolabs | inquire | Ask for price |
Description: rREBOV GPDTM, recombinant protein from Sf9 cells. |
|||
Rat Soluble RANK Ligand Recombinant Protein Lyophilized |
|||
IRTSRANKLGRLY2UG | Innovative research | each | 341 EUR |
Description: Rat Soluble RANK Ligand Recombinant Protein Lyophilized |
|||
BAFF, Soluble 60-mer highly active Recombinant Protein |
|||
90-294 | ProSci | 10 ug | 537.9 EUR |
Description: BAFF is mainly produced by innate immune cells such as neutrophils, monocytes, macrophages, dendritic cells, follicular dendritic cells. T cells, activated B cells, some malignant B cells and also non-lymphoid cells like astrocytes, synoviocytes and epithelial cells can also produce BAFF. BAFF binds three distinct receptors (BAFF-R, TACI and BCMA) expressed predominantly on B cells, although activated T cells also express BAFF-R. BAFF is a master regulator of peripheral B cell survival, and together with IL-6, promotes Ig class-switching and plasma cell differentiation. Besides its major role in B cell biology, BAFF co-stimulates activated T cells. Deregulated expression of BAFF leads to autoimmune disorders in mice. In humans, elevated levels of soluble BAFF have been detected in the serum of patients with various autoimmune diseases such as Sjoegren syndrome, Rheumatoid arthritis (RA), Multiple sclerosis (MS) and Systemic Lupus Erythematosus (SLE). BAFF has also increased levels in some lymphoid cancers. Processed human BAFF can either remain as a trimer, which is usual for TNF family ligands or assemble into 60-mer composed of 20 trimers. Mouse BAFF 60-mer has been identified in the serum of BAFF transgenic mice. Oligomerization of BAFF 3-mer into 60-mer in human BAFF is prevented by mutation of His218, a residue critical for 3-mer-to-3-mer interactions, but not for receptor binding. Despite the predominant functional role of processed BAFF in vivo, membrane-bound BAFF might also play a role. Indeed, soluble BAFF (3-mer) can trigger BAFF-R but not TACI or BCMA, whereas oligomeric forms of BAFF (BAFF 60-mer), which mimic membrane-bound BAFF, activate all BAFF receptors. |
|||
Recombinant Human Soluble Iinterleukin-2 Receptor alpha |
|||
7-00826 | CHI Scientific | 5µg | Ask for price |
Recombinant Human Soluble Iinterleukin-2 Receptor alpha |
|||
7-00827 | CHI Scientific | 25µg | Ask for price |
Recombinant Human Soluble Iinterleukin-2 Receptor alpha |
|||
7-00828 | CHI Scientific | 1mg | Ask for price |
Recombinant Human Soluble Iinterleukin-2 Receptor alpha |
|||
CC038-005 | GenDepot | 5ug | 351.6 EUR |
Recombinant Human Soluble Iinterleukin-2 Receptor alpha |
|||
CC038-025 | GenDepot | 25ug | 489.6 EUR |
Recombinant Human Soluble Iinterleukin-2 Receptor alpha |
|||
CC038-101 | GenDepot | 1mg | 8970 EUR |
Recombinant EBOV VP40 Matrix Protein |
|||
VAng-Lsx0144-100g | Creative Biolabs | 100 µg | 712.8 EUR |
Description: EBOV VP40, recombinant protein from E. coli. |
|||
Human Soluble RANK Ligand Recombinant Protein Lyophilized |
|||
IHUSRANKLGRLY2UG | Innovative research | each | 341 EUR |
Description: Human Soluble RANK Ligand Recombinant Protein Lyophilized |
|||
Mouse Soluble CD40 Ligand Recombinant Protein Lyophilized |
|||
IMSSCD40LGRLY5UG | Innovative research | each | 341 EUR |
Description: Mouse Soluble CD40 Ligand Recombinant Protein Lyophilized |
|||
Mouse Soluble RANK Ligand Recombinant Protein Lyophilized |
|||
IMSSRANKLGRLY2UG | Innovative research | each | 341 EUR |
Description: Mouse Soluble RANK Ligand Recombinant Protein Lyophilized |
|||
Recombinant Human Soluble Interleukin-6 (IL-6) Receptor |
|||
4598-20 | Biovision | each | 332.4 EUR |
Human Soluble Fas Receptor Recombinant Protein Lyophilized |
|||
IHUSFASRLY5UG | Innovative research | each | 341 EUR |
Description: Human Soluble Fas Receptor Recombinant Protein Lyophilized |
|||
Human SuperKillerTRAIL, Soluble Recombinant Protein His Tag |
|||
IHUSKLTRAILSRHIS20UG | Innovative research | each | 802 EUR |
Description: Human SuperKillerTRAIL, Soluble Recombinant Protein His Tag |
|||
Human Soluble RANK Receptor Recombinant Protein Lyophilized |
|||
IHUSRANKRLY20UG | Innovative research | each | 341 EUR |
Description: Human Soluble RANK Receptor Recombinant Protein Lyophilized |
|||
PRL-R Prolactin Soluble Receptor Rat Recombinant Protein |
|||
PROTP05710 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: Prolactin Receptor Rat Extra Celleular Domain Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 206 amino acids and having a molecular mass of 24120 Dalton. ;The Prolactin Receptor is purified by proprietary chromatographic techniques. |
|||
Recombinant Phosphoenolpyruvate Carboxykinase 1, Soluble (PCK1) |
|||
4-RPA936Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Phosphoenolpyruvate Carboxykinase 1, Soluble expressed in: E.coli |
|||
Recombinant Phosphoenolpyruvate Carboxykinase 1, Soluble (PCK1) |
|||
4-RPA936Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Phosphoenolpyruvate Carboxykinase 1, Soluble expressed in: E.coli |
|||
Human / Mouse KillerTRAIL, Soluble Recombinant Protein His Tag |
|||
IHUMSKLTRAILSRHIS50UG | Innovative research | each | 802 EUR |
Description: Human / Mouse KillerTRAIL, Soluble Recombinant Protein His Tag |
|||
PRL-R Prolactin Soluble Receptor Human Recombinant Protein |
|||
PROTP16471 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: Extra Cellular Domain Prolactin Receptor Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containsing 210 amino acids and having a molecular mass of 23.97 kDa. ;The Prolactin Receptor is purified by proprietary chromatographic techniques according to Bignon et al. (1994) JBC 269; 3318-24 and tested according to Gertler et al. (1996) JBC 271; 24482-91. |
|||
Recombinant EBOV GP Protein (aa 1-650) [His] (subtype Zaire, strain Mayinga 1976) |
|||
VAng-Wyb6907-100g | Creative Biolabs | 100 µg | 2281.2 EUR |
Description: Ebola virus (subtype Zaire, strain Mayinga 1976) Glycoprotein, recombinant protein. |
|||
Recombinant EBOV GP Protein (aa 1-650) [His] (subtype Zaire, strain Mayinga 1976) |
|||
VAng-Wyb6907-20g | Creative Biolabs | 20 µg | 940.8 EUR |
Description: Ebola virus (subtype Zaire, strain Mayinga 1976) Glycoprotein, recombinant protein. |
|||
PRL-R Prolactin Rabbit Soluble Receptor Recombinant Protein |
|||
PROTP14787 | BosterBio | Regular: 20ug | 380.4 EUR |
Description: Prolactin Receptor Rabbit Extra Celleular Domain Recombinant ?produced in E.Coli is a non-glycosylated, Polypeptide chain containing 207 amino acids and having a molecular mass of 23972 Dalton. ;The Prolactin Receptor is purified by proprietary chromatographic techniques. |